Skip to main content
Log in

Chloramphenicol

Are Concerns About Aplastic Anaemia Justified?

  • Leading Article
  • Published:
Drug Safety Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Best WR. Chloramphenicol associated blood dyscrasias. Journal of the American Medical Association 201: 181–188, 1967

    Article  Google Scholar 

  • Erlich J, Bartz QR, Smith RM, Joslyn DA, Burkholder PR. Chloromycetin, a new antibiotic from a soil actinomycete. Science 106: 417–419, 1947

    Article  Google Scholar 

  • Fraundfelder FT, Meyer SM. Systemic reactions to ophthalmic drug preparations. Medical Toxicology 2: 287–293, 1987

    Google Scholar 

  • Hausmann K, Skrandies G. Aplastic anaemia following chlorapmphenicol therapy in Hamburg and surrounding districts. Postgraduate Medical Journal 50 (Suppl. 5): 1331, 1974

    Google Scholar 

  • Keizer G. Cooperative study of patients treated with thiamphenicol. Comparative study of patients treated with chloramphenicol and thiamphenicol. Postgraduate Medical Journal 50 (Suppl.): 132–145; 1974

    Google Scholar 

  • Kumana CR, Li KY, Chau PY. Worldwide variation in chloramphenicol utilisation: should it cause concern? Journal of Clinical Pharmacology 28: 1071–1075, 1988

    PubMed  CAS  Google Scholar 

  • Martello OJ, Manyan DR, Smith US, Yunis AA. Chloramphenicol and bone marrow mitochondria. Journal of Laboratory and Clinical Medicine 74: 927–929, 1969

    Google Scholar 

  • Nagao T, Mauer AM. Concordance for drug-induced aplastic anaemia in identical twins. New England Journal of Medicine 281: 7–11, 1969

    Article  PubMed  CAS  Google Scholar 

  • Petska S. Inhibition of ribosome function. Annual Review of Microbiology 25: 487–562, 1971

    Article  Google Scholar 

  • Rich ML, Ritterhoff RJ, Hoffman RJ. A fatal case of aplastic anaemia following chloramphenicol (Chloromycetin) therapy. Annals of Internal Medicine 33: 1459–1467, 1950

    PubMed  CAS  Google Scholar 

  • Sande MA, Mandell GL. Tetracycline, chloramphenicol, eryth-romycin and miscellaneous antibacterial agents. In Goodman & Gilman (Eds) The pharmacological basis of therapeutics, 8th ed., pp. 1117–1145, MacMillan, Toronto, 1990

    Google Scholar 

  • Staniford HC. Tetracycline and chlorapmphenicol. In Mandell et al. (Eds) Principles and practice of infectious diseases, 3rd ed., pp. 284–295, John Wiley and Sons, New York, 1990

    Google Scholar 

  • Tisne M. Ten years of clinical experience with thiamphenicol in France. Postgraduate Medical Journal 50 (Suppl. 50): 142, 1974

    Google Scholar 

  • Wallerstein RO, Condit PK, Kasper CK, Brown JW, Morrison FR. Statewide study of chloramphenicol therapy and fatal aplastic anaemia. Journal of the American Medical Association 208: 2045–2050, 1969

    Article  PubMed  CAS  Google Scholar 

  • West BC, DeVault GA, Clement JC, Williams DM. Aplastic anaemia associated with parenteral chloramphenicol: review of 10 cases including the second case of possible increased risk with cimetidine. Reviews of Infectious Diseases 10: 1048–1051, 1988

    Article  PubMed  CAS  Google Scholar 

  • Yogev R, William ST. Ventricular fluid levels of chloramphenicol and paracetamol. Antimicrobial Agents and Chemotherapy 16: 7–8, 1979

    Article  PubMed  CAS  Google Scholar 

  • Yunis AA. Chloramphenicol toxicity: 25 years of research. American Journal of Medicine 87: 44–48, 1989

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Flegg, P., Cheong, I. & Welsby, P.D. Chloramphenicol. Drug-Safety 7, 167–169 (1992). https://doi.org/10.2165/00002018-199207030-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199207030-00001

Keywords

Navigation